United Kingdom Pacemaker Market Size, Share, and COVID-19 Impact Analysis, By Product (External, Implantable), By Application (Arrhythmias, Congestive Heart Failure, Bradycardia, Acute Myocardial Infarction, Atrial Fibrillation, Heart Block, Long QT Syndrome, Others), and United Kingdom Pacemaker Market Insights, Industry Trend, Forecasts to 2035.

United Kingdom Pacemaker Market Insights Forecasts to 2035

• The United Kingdom Pacemaker Market Size was estimated at USD 378.5 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 3.88% from 2025 to 2035
• The United Kingdom Pacemaker Market Size is Expected to Reach USD 575.56 Million by 2035

According to a research report published by Spherical Insights & Consulting, The United Kingdom Pacemaker Market Size is Anticipated to reach USD 575.56 Million By 2035, Growing at a CAGR of 3.88% from 2025 to 2035. The aging population and a rising incidence of cardiovascular diseases in the UK are factors influencing the market expansion.  

Market Overview

The United Kingdom pacemaker market refers to the industry focused on the production and application of the clinical device known as a pacemaker is used to activate the lower chambers of the heart or to maintain a normal pulse by sending tiny driving forces to the heart muscles. Hypertrophic cardiomyopathy, congestive cardiovascular failure, and syncope are among the conditions it is used to treat. Favourable reimbursement policies and legislative backing have a significant effect on the pacemaker market. Further, offering financing for pacemaker placement, governments and medical facilities increase access to modern cardiac treatment and reduce expenses for patients. Concurrently, strong support from the regulatory agencies, such as the UK Medicines and Healthcare Products Regulatory Agency (MHRA), approved Ceryx Medical’s clinical trial authorization application for the pilot RSA-pace study of the Cysoni-XT system for post-cardiac surgery patients. Cysoni-XT is a temporary cardiac pacemaker designed to enhance cardiac performance by resynchronizing the heart and lungs through Respiratory Sinus Arrhythmia (RSA). The RSA-pace study marked the first time RSA therapy had been evaluated in patients.

Report Coverage

This research report categorizes the market for the United Kingdom pacemaker market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom pacemaker market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom pacemaker market.

Driving Factors

The market for the United Kingdom pacemaker is driven by the rising demand for minimally invasive procedures, government and private support for the healthcare sector. The market is expanding as a result of the presence of significant healthcare medical device businesses and rising rates of hypertension. The rise of the market is being driven by the rising demand for surgical procedures such as endocardial or epicardial for pacemaker insertion. The market is driven by technological advances that improve the overall efficiency, dependability, and safety of devices, such as leadless pacemakers, MRI-compatible devices, and rechargeable pacemakers.

Restraining Factors

The high cost of the pacemaker installation process and potential concerns associated with the device, such as bleeding, and surgical site infection, are expected to limit market growth.

Market Segmentation

The United Kingdom pacemaker market share is classified into type, product, and application.

• The implantable segment held the highest share in 2024 and is anticipated to grow at a significant CAGR over the forecast period.

The United Kingdom pacemaker market is segmented by product into external, and implantable. Among these, the implantable segment held the highest share in 2024 and is anticipated to grow at a significant CAGR over the forecast period. This is because of the rise in bradycardia cases and the rise in the prevalence of coronary heart disease. Besides, the aging population and the development of innovation in the medical services sector also contribute to the segment growth.

• The arrhythmias segment held a significant share in 2024 and is expected to grow at a rapid pace during the forecast period.

The United Kingdom pacemaker market is divided by application into arrhythmias, congestive heart failure, bradycardia, acute myocardial infarction, atrial fibrillation, heart block, long QT syndrome, and others. Among these, the arrhythmias segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The cardiovascular arrhythmia is becoming more common due to several factors, including smoking, weight, excessive alcohol consumption, and lifestyle choices. There is a high frequency of irregular heart rhythms that need to be treated, so it will be cured by pacemaker implantation and restore normal cardiac function, and avoid potentially fatal complications.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom pacemaker market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• APC Cardiovascular Ltd
• PACENET (Clinical Network Systems)
• Cardio Health
• BB Cardiology
• Heart Rhythm Solutions Ltd
• Others

Recent Developments:

• In September 2024, Abbott officially launched its Aveir dual-chamber leadless pacemaker system in the UK. This device was designed to treat people with abnormal or slow heart rhythms and was the world’s first dual-chamber leadless pacemaker. Unlike traditional pacemakers, leadless devices were implanted directly into the heart through a minimally invasive procedure, eliminating the need for cardiac leads.

• In November 2022, Heart experts at University Hospital Southampton (UHS) became the first in the UK to implant a new leadless pacemaker defibrillator system. This breakthrough procedure was part of a global clinical trial and involved fitting two devices: the subcutaneous implantable cardioverter-defibrillator (S-ICD) and the EMPOWER leadless pacemaker.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom pacemaker market based on the below-mentioned segments

United Kingdom Pacemaker Market, By Product

• External
• Implantable

United Kingdom Pacemaker Market, By Application

• Arrhythmias
• Congestive Heart Failure
• Bradycardia
• Acute Myocardial Infarction
• Atrial Fibrillation
• Heart Block
• Long QT Syndrome
• Others